PROGRAM

PRELIMINARY PROGRAM

23th October

09:30-09:45 Opening

09:45-10:15 Plenary lecture: Treatment of gastric cancer-present state and perspectives. Ivan Stilidi (Russia)

10:15-10:45 Plenary lecture: New Concepts of Immune Checkpoint Inhibitor Treatment: Is Neoadjuvant Therapy an Option and Why? Christoph Zielinski (Austria)

COURSE A. ESOPHAGEAL & GASTRIC CANCER | ROOM 1 COURSE B. ОNCOGYNECOLOGY | ROOM 2 COURSE C. LUNG CANCER | ROOM 3

11:00-13:40 

Session A1. Surgical treatment of Esophageal and Gastric cancer

  • Staging and classification of gastric and esophago-gastric junction cancer. Michail Ter-Ovanesov (Russia)
  • Surgical treatment of patients with cancer of the esophagus and cardia. Pavel Kononets (Russia)
  • Surgical treatment of patients with gastric cancer. Alexey Kalinin (Russia)
  • Laparoscopic surgery for early gastric cancer. Maxim Nikulin (Russia)
  • Laparoscopic surgery of locally advanced gastric cancer. Igor Khatkov, Roman Izrailov (Russia)
  • Surgical removal of primary tumor in patients with primary metastatic gastric cancer: yes/ no. Natalia Besova (Russia)

13:40-14:30 - Break

14:30-16:00 

Session A2. Epidemiology and Prevention

  • Esophageal cancer: epidemiology and prevention. Eva Negri (Italy)
  • Gastric cancer: epidemiology and prevention. Carlo La Vecchia (Italia)
  • Early endoscopic diagnosis and treatment of gastric cancer. Olga Malikhova (Russia)
  • Hereditary esophageal and gastric cancer. Ludmila Lubchenko (Russia)

11:00-13:30 

Session B1. Epidemiology and Prevention

  • Incidence and mortality of HPV-related cancersDavid Zaridze (Russia) 
  • National programs of HPV vaccination: implementation and results. Joakim Dillner (Sweden)
  • HPV-FASTER. Vaccinating adult women. Joakim Dillner (Sweden)
  • HPV screening for cervical cancer. 

    Jack Сuzick (United Kingdom)

  • Projection of cervical cancer incidence in the cohorts of vaccinated and not vaccinated Russian women. vaccination and not vaccinated Russian women. Iacopo Baussano (IARC, France)    
  • Validated HPV test systems for cervical cancer screening. Mario Poljak (Slovenia)
  • HPV screening. Russian experience. Ilya Olkov (Russia)
  • The causes of failure in cytological screening for cervical cancer. Preinvasive disease.  Lubov Korolenkova (Russia)

13:40-14:30 - Break

14:30-17:00 

Session B2. Cervical cancer

  • Mechanism of HPV Carcinogenesis. Svetlana Vinokurova (Russia)
  • Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.  Heinz Kölbl (Austria)
  • The Organ saving treatment of cervical cancer.  Аlexey Shevchuk (Russia)
  • Systemic treatment of cervical cancer (early and advanced). Anna Kedrova (Russia)
  • Immunotherapy of cervical cancer. Anna Kedrova (Russia)
  • Cervical cancer and pregnancy.  Lubov Korolenkova (Russia)
  • HPV  vaccination of  patients after primary treatment of  HPV associated cervical precancerous lesions and cancer. Olga Trushinа (Russia)  

11:00-12:00

Session C1. Immunotherapy of NSCLC 

  • Immune Checkpoint Inhibitors in treatment of NSCLC. Sergey Orlov (Russia)

  • Immune Checkpoint Inhibitors in treatment of SCLC. Elena Artamonova (Russia)

12:10-13:30

Session С2. Epidemiology and prevention

  • Epidemiology and prevention of lung cancer. David Zaridze (Russia)

  • Smoking cessation after diagnosis improves prognosis of lung cancer patients. Anush Mukeria (Russia)
  • Screening for lung cancer. Andre Carvalho (France) 

13:40-14:30 - Break

14:30-15:30

Session С3. Surgical treatment

  • Interventional Bronchoscopy for management of early lung cancer. Olga Malikhova (Russia)

  • Open surgery in treatment of NSCLC. Walter Klepetko (Austria)

  • Video - Assisted Thoracoscopic Surgery (VATS). Pavel Kononetc (Russia)

 

 

 

 

24th October

9.00-9.30 Registration

COURSE A. ESOPHAGEAL & GASTRIC CANCER | ROOM 1 COURSE B. ОNCOGYNECOLOGY | ROOM 2 COURSE C. LUNG CANCER | ROOM 3

09:30-11:30 

Session A3. Medical Treatment of Esophageal & Gastric cancer

  • Standard chemotherapy plus / minus VEGF inhibitors. Alexey Tryakin (Russia)
  • Her-2/neu Targeting in Gastric Cancer: Upcoming Drugs
  • Christoph Zielinski (Austria)
  • Immune Checkpoint Inhibitors in Gastric Cancer. Christoph Zielinski (Austria)
  • Personalized medical treatment of patients with primary disseminated gastric cancer.  Natalia Besova (Russia)
  • Radiotherapy (brachytherapy) for cancer of the esophagus. Irina Gladilina (Russia) 

09:30-12:00

Session B3. Сancer of the ovary

  • Genetic susceptibility to ovarian cancer. Eugeniy Imyanitov (Russia)
  • Classification. Subtypes. Primary site assignment. Kirill Zhordaniа (Russia)
  • Surgery: Primary and interval debulking surgery. Valentina Nechushkina (Russia)
  • Standard therapy. Targeted therapy plus minus VEGF inhibitors. Immunotherapy?  Alexandra Tulyandina (Russia)
  • Management of BRCA mutation associated ovarian cancer. Andrey Mechsheryakov (Russia)
  • anagement of recurrent disease. Debulking surgery: pro/contra? Systemic treatment.  Alexey Schevchuk (Russia)
  • Management of brain metastasis of ovarian cancer. David Naskhletashvili (Russia)       

12:00-12:20

Session B4. Endometrial cancer

  • Session B4. Cancer of the vulva and vagina
  • Cancer of the vulva and vagina - Diagnostic assessment, staging, surgical treatment and adjuvant radiotherapy. Elena Ulrikh (Russia)

12:20-13:00 - Break 

13:00-14:00

Session B5. Endometrial cancer

  • Surgical treatment: Minimally invasive surgery, total hysterectomy with bilateral salpingo-oophorectomy with or without removal of pelvic and para-aortic lymph nodes. Heinz Kölbl (Austria)
  • Current status of brachytherapy in oncogynecology - modern principles, concepts, clinical results. Olga Kravets (Russia)
  • Malignant trophoblastic disease. Ludmila Meshcheryakova (Russia)

09:30-11:30

Session С4. Targeted therapy

    Molecular characteristics of NSCLC. Lynnette Fernandez Cuesta (France)

  • Treatment of EGFR positive NSCLC. Tanja Cufer (Slovenia) 

  • Treatment of ALK positive NSCLC. Tanja Cufer (Slovenia)

  • Systematic therapy of advanced driver mutation-negative NSCLC. Christian Manegold (Germany)

    Management of brain metastases in advanced driver mutation-positive NSCLC. David Naschletashvili (Russia)

    Molecular characteristics of SCLC and neuro-endocrine lung tumours: the impact on their clinical management. Lynnette Fernandez Cuesta (France)

12:00-13:00

Session С5Imaging diagnostics

  • Imaging modalities. Igor Tyurin (Russia) 

  • Image-guided intervention diagnosis.Dimitry Marinov (Russia)

13:00-14:00

Session С6Radiotherapy

  • Radiofrequency Ablation (RFA). Vladislav Kosirev (Russia)
  • Stereotactic body radiotherapy. Alexey Nazarenko (Russia)

 

 

back to top